Latest Articles
European Commission expands Jemperli plus chemotherapy approval for endometrial cancer - Indian Pharma Post
European Commission expands Jemperli plus chemotherapy approval for endometrial cancer Indian Pharma Post
Published: Jan. 21, 2025, 4:36 a.m.
Personalizing Radiotherapy for Endometrial Cancer: Balancing Innovation and Quality of Life - Journal of Clinical Pathways
Personalizing Radiotherapy for Endometrial Cancer: Balancing Innovation and Quality of Life Journal of Clinical Pathways
Published: Jan. 17, 2025, 2:21 p.m.
Ortho-pelvic physical therapy and it’s benefits - WFLA
Ortho-pelvic physical therapy and it’s benefits WFLA
Published: Jan. 15, 2025, 10:02 p.m.
Editorial: Advances in the Pharmacotherapy of Chronic Pelvic Pain Conditions - Frontiers
Editorial: Advances in the Pharmacotherapy of Chronic Pelvic Pain Conditions Frontiers
Published: Jan. 14, 2025, 10:43 a.m.
Brian Slomovitz on Adjuvant Pembrolizumab/Chemotherapy for Advanced Endometrial Cancer - «Кавказ Пост» - новости Северного Кавказа и Закавказья
Brian Slomovitz on Adjuvant Pembrolizumab/Chemotherapy for Advanced Endometrial Cancer «Кавказ Пост» - новости Северного Кавказа и Закавказья
Published: Jan. 12, 2025, 2:45 a.m.
A novel mitochondrial-related risk model for predicting prognosis and immune checkpoint blockade therapy response in uterine corpus endometrial carcinoma - Nature.com
A novel mitochondrial-related risk model for predicting prognosis and immune checkpoint blockade therapy response in uterine corpus endometrial carcinoma Nature.com
Published: Jan. 9, 2025, 7:28 a.m.
Multimodal physical therapy proves effective for women with chronic pelvic pain - Contemporary Obgyn
Multimodal physical therapy proves effective for women with chronic pelvic pain Contemporary Obgyn
Published: Jan. 6, 2025, 9:51 p.m.
Unveiling Immunogenic Characteristics and Neoantigens in Endometrial Cancer with POLE Hotspot Mutations for Improved Immunotherapy - Frontiers
Unveiling Immunogenic Characteristics and Neoantigens in Endometrial Cancer with POLE Hotspot Mutations for Improved Immunotherapy Frontiers
Published: Jan. 6, 2025, 6:36 p.m.
Machine learning Nomogram for Predicting endometrial lesions after tamoxifen therapy in breast Cancer patients - Nature.com
Machine learning Nomogram for Predicting endometrial lesions after tamoxifen therapy in breast Cancer patients Nature.com
Published: Jan. 6, 2025, 3:49 p.m.
Multiple Subcutaneous Metastases in Endometrial Cancer Treated With Systemic Chemotherapy: A Case Report and Review of the Literature - Cureus
Multiple Subcutaneous Metastases in Endometrial Cancer Treated With Systemic Chemotherapy: A Case Report and Review of the Literature Cureus
Published: Jan. 5, 2025, 6:05 a.m.
Link copied to clipboard!